beta

CRTX

Cortexyme Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in patients with mild to moderate Alzheimer's disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models.

Market Cap: 1.41 Billion

Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)

Website: www.cortexyme.com

Shares Outstanding: 29.6 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.685075567617791

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Ethical Flags

Longest drawdown: 397 trading days

From: 2020-02-14 To: 2021-06-15

Lowest Point:

Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019

via: Business Wire at 2019-06-10 04:00:00:000

-- Event will be webcast, with Cortexyme presentation expected to start at 2:05 p.m. EDT tomorrow afternoon Cortexyme, Inc. (Nasdaq: CRTX) today announced that Casey Lynch, the companys chief executive officer, chairman, and co-founder, will present at a National Academies o… read more...

Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019

via: Business Wire at 2019-06-10 04:00:00:000

-- Event will be webcast, with Cortexyme presentation expected to start at 2:05 p.m. EDT tomorrow afternoon Cortexyme, Inc. (Nasdaq: CRTX) today announced that Casey Lynch, the companys chief executive officer, chairman, and co-founder, will present at a National Academies o… read more...

Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019

via: Business Wire at 2019-06-10 04:00:00:000

-- Event will be webcast, with Cortexyme presentation expected to start at 2:05 p.m. EDT tomorrow afternoon Cortexyme, Inc. (Nasdaq: CRTX) today announced that Casey Lynch, the companys chief executive officer, chairman, and co-founder, will present at a National Academies o… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud